Kinnari Patel - President, Head of R&D and Chief Operating Officer at Rocket Pharmaceuticals, Inc.

Insider Transactions and Holdings

Entity Type
Individual
Role
President, Head of R&D and Chief Operating Officer
Stock Symbol
RCKT, RCKTW on Nasdaq
All Insider Reports
All Insider Reports

Kinnari Patel - trading volume in the past year for Rocket Pharmaceuticals, Inc.

Holdings reported by Kinnari Patel for Rocket Pharmaceuticals, Inc.

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Stock Option (Right to Buy) 172K $2.59M $15.04 Feb 11, 2025 Direct Common Stock
Common Stock 444K $2.09M $4.70 Apr 9, 2025 Direct
Common Stock 105K $493K $4.70 Apr 9, 2025 By Adaptive Technology LLC
Common Stock 26.8K $126K $4.70 Apr 9, 2025 By Spouse

Transactions reported by Kinnari Patel for Rocket Pharmaceuticals, Inc.

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.